84 Participants Needed

Exercise for Colorectal Cancer

Christina M Dieli-Conwright, PhD profile photo
Overseen ByChristina M Dieli-Conwright, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how exercise (also known as physical activity, workout, or fitness training) affects the gut microbiome, chemotherapy side effects, and overall treatment outcomes for individuals undergoing chemotherapy for colorectal cancer. Participants will be divided into two groups: one will engage in regular exercise sessions, while the other will maintain their usual activity level and join the exercise program later. Individuals with early-stage or metastatic colorectal cancer, who are undergoing chemotherapy and currently exercise less than 90 minutes per week, might be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research on exercise and cancer treatment.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with your doctor or the study team.

What prior data suggests that exercise is safe for individuals with colorectal cancer?

Research shows that exercise is generally safe for people with colorectal cancer. A review of studies found that exercise after a colorectal cancer diagnosis links to a low risk of negative side effects, indicating that most people handled the exercise well without serious issues.

One study found that colon cancer survivors who exercised regularly had a 28% lower chance of cancer recurrence. Additionally, those who followed a structured exercise program had a 37% lower risk of death. These findings suggest that exercise is not only safe but might also provide important health benefits for those with colorectal cancer.

Overall, exercise appears to be a well-tolerated and potentially beneficial activity for people with colorectal cancer.12345

Why are researchers excited about this trial?

Researchers are excited about using exercise as a treatment for colorectal cancer because it offers a non-invasive, drug-free approach that can complement existing therapies like surgery, chemotherapy, and radiation. Unlike traditional treatments that often have significant side effects, exercise may enhance patients' overall well-being and potentially improve treatment outcomes by boosting physical fitness and reducing fatigue. Additionally, exercise can be easily integrated into daily life, making it an accessible option for many patients seeking to enhance their quality of life during and after cancer treatment.

What evidence suggests that exercise is effective for colorectal cancer?

Research has shown that exercise might benefit people with colorectal cancer. One study found that physical activity reduced the risk of colon cancer by 24%. Another study demonstrated that exercising after surgery and chemotherapy lowered the chance of cancer recurrence or new cancer development. Over eight years, participants who exercised had better survival rates. Exercise also improved the quality of life for colorectal cancer survivors. This trial will compare an Exercise Group, where participants will complete exercise sessions three times weekly, with a Waitlist Control Group, who will maintain their usual activities. This evidence suggests that exercise could be helpful for those with colorectal cancer.26789

Who Is on the Research Team?

Christina M. Dieli-Conwright, PhD, MPH ...

Christina M Dieli-Conwright, PhD

Principal Investigator

Dana-Farber Cancer Institute

Are You a Good Fit for This Trial?

This trial is for individuals with early-stage or metastatic colorectal cancer who are currently undergoing chemotherapy. Participants should be willing to either engage in an exercise program or be placed on a waitlist as part of the control group.

Inclusion Criteria

Participate in less than or equal to 90 minutes of moderate-to-vigorous exercise per week
My doctor says I can safely do exercise and tests.
I don't plan to have major surgery during the next 12 weeks, except for a port placement.
See 8 more

Exclusion Criteria

Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Unstable comorbidities that prevent participation in moderate-to-vigorous intensity exercise
Participate in more than 90 minutes of moderate-to-vigorous aerobic exercise per week over the past month

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants undergo chemotherapy and are assigned to either an exercise group or a waitlist control group. The exercise group completes exercise sessions 3 times weekly.

12 weeks
Baseline and post-intervention in-office visits

Follow-up

Participants are monitored for changes in microbiome activity and chemotherapy toxicity after the intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Exercise
Trial Overview The COURAGE Trial is testing whether an exercise program can influence gut microbiome activity, reduce side effects from chemotherapy, and improve treatment outcomes for young-onset colorectal cancer patients compared to those not exercising.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Group A: Exercise GroupExperimental Treatment1 Intervention
Group II: Group B: Waitlist Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+

American Cancer Society, Inc.

Collaborator

Trials
237
Recruited
110,000+

Published Research Related to This Trial

In the CAN-HOPE trial involving 69 colorectal cancer survivors, participants reported not meeting the minimum exercise guidelines in 39.2% of the weeks, highlighting significant challenges in adherence to exercise recommendations.
The most common barriers to exercise included lack of time, treatment side effects, and fatigue, which accounted for 70% to 80% of missed exercise weeks, suggesting targeted interventions could help improve adherence.
A longitudinal study of exercise barriers in colorectal cancer survivors participating in a randomized controlled trial.Courneya, KS., Friedenreich, CM., Quinney, HA., et al.[2022]
A 12-week supervised exercise program significantly improved cardiorespiratory fitness, muscle strength, and quality of life in colorectal cancer patients undergoing chemotherapy compared to usual care.
The exercise intervention led to better outcomes in physical activity levels and reduced pain and emotional distress, suggesting that incorporating exercise into treatment plans can enhance the overall well-being of these patients.
Comparison of the effects of a supervised exercise program and usual care in patients with colorectal cancer undergoing chemotherapy.Lin, KY., Shun, SC., Lai, YH., et al.[2022]
Physical activity is beneficial for colorectal cancer survivors, as it can reduce the risk of colon cancer recurrence and improve overall quality of life and cardiovascular health, based on a review of existing data.
While the evidence for rectal cancer survivors is less strong, physical activity still shows positive effects on quality of life and health outcomes, potentially through mechanisms involving inflammation and insulin-like growth factors.
Colorectal cancer survivorship: movement matters.Denlinger, CS., Engstrom, PF.[2021]

Citations

Exercise Proves Powerful in Preventing Colon CancerOver nearly eight years, the results were striking: disease-free survival at five years was 80.3% in the exercise group, compared to 73.9% in ...
Effect of exercise on colorectal cancer prevention and treatmentA meta-analysis showed that physical activity resulted in a 24% decrease in colon cancer risk [risk ratio (RR): 0.76, 95% confidence interval (CI): 0.72โ€“0.81][ ...
Structured Exercise Program May Lower Risk of Cancer ...New study results show that a structured exercise program following surgery and adjuvant chemotherapy reduced the risk of recurrent or new cancer and increased ...
Exercise and colorectal cancer: prevention and molecular ...A huge number of clinical trials and meta-analysis have demonstrated that exercise is significantly effective in lowering the risk of colorectal cancer.
Physical Activity Interventions for Colorectal Cancer SurvivorsPhysical activity interventions significantly improved disease-specific quality of life, PA level, and maximum amount of oxygen and did not show significant ...
Structured Exercise after Adjuvant Chemotherapy for Colon ...Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking.
New Study Shows Benefits of Physical Activity for Colon ...Colon cancer survivors who took part in a three-year structured exercise program had a 28 percent lower risk of cancer recurrence or a second ...
Exercise and colorectal cancer: a systematic review and meta ...The present findings suggest that exercise following colorectal cancer diagnosis is associated with a low risk of adverse event, is feasible, ...
World-first trial highlights survival benefits of exercise for ...Patients had over a third (37%) lower risk of death if they participated in the structured exercise program. Every year, around 31,800 people ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity